By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Personalized Treatment For Metastatic Colorectal Cancer
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Innovations > Personalized Treatment For Metastatic Colorectal Cancer
Medical InnovationsPublic Health

Personalized Treatment For Metastatic Colorectal Cancer

Joey
Joey
Share
3 Min Read
SHARE

Colorectal Cancer

Colon and rectum comprise a large intestine. The presence of cancerous cells in either colon or rectum is termed as colorectal cancer or colon cancer.

Metastatic Colorectal Cancer

Colorectal Cancer

More Read

Innovation without Diligence Negatively Impacts Healthcare Access
CIN Special Report: Part II, Treatments Ready to Eradicate Pre-Cervical Cancer
Doctors and Patients Have a Failure to Communicate
Expanding Insurance May Not Mean Long Lines and Trouble Seeing the Doctor
Scanadu Rocks Indiegogo For $1.1M … And Counting

Colon and rectum comprise a large intestine. The presence of cancerous cells in either colon or rectum is termed as colorectal cancer or colon cancer.

Metastatic Colorectal Cancer

When the tumor extends beyond the colon to the nearby organs, then it is termed as metastatic colorectal cancer. In most cases, the cancer advances to the liver, lungs and bones. It is the most dangerous phase of cancer and treatments become less effective for the patient’s, whose cancer has metastasized.

Colorectal cancer is responsible for taking almost 50,000 lives each year in USA, but with better understanding of this disease and advanced treatment methods the survival rates have improved.

Personalized Treatment

Mostly patients of colon cancer recieve traditional treatments (surgery, chemo, radiation) regardless of the particular characterics of the tumor and patient’s condition. The purpose of a personalized treatment is to choose the most effective treatment for a particular patient to achieve ultimate effectiveness with slightest side effects. It has been realized by the professionals that the characteristics of colorectal cancer are not same in any two patients. Therefore personalized treatment means that treating the patient according to the molecular characteristics of tumor in a particular patient. Standard procedures like surgery, chemotherapy and radiation treatment might not be effective for a particular case of metastatic colorectal cancer. However, targeted therapies along with conventional therapies have proved to be more effective and this combination is emerging as best cancer treatment. Through personalized treatment, one can avoid the unnecessary side effects of the useless treatment methods.

Personalized Medicine: Through biomakers (molecular characteristics of cancer), doctors decide, which medicines would be more effective for a particular patient of metastatic colon cancer. In almost 40-50% cases of metastatic colon cancer changes in KRAS gene are present. With presence of KRAS gene mutation, chemotherapy drugs (cetuximab (Erbitux) and panitumumab (Vectibix)) are ineffective. Every meatastatic colon cancer patient must be tested for KRAS gene mutations.

Personalized Targeted Therapies: These therapies have a great future in treating advace stage colon cancer patients. These therapies are designed to destroy particular cancerous cells in a patient. It may involve different combinations of chemotherapy drugs for different stages of colorectal cancer.

A personalised care plan offers bright chances of sucessful outcomes.In last 10 years advacements have been made in altering treatments based on moleculer markers. It is conceived  that approved clinical biomarkers will evolve as a new standard of treatment in future and will accurately predict the response to specific therapies. Endeavors are required to recognize predictive markers for better and accurate therapeutic decisions.

 

TAGGED:cancercolon cancerpersonalized treatment
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Epidemiological Health Benefits
Personal and Epidemiological Health Benefits of Blood Pressure Management
Health
October 13, 2025
Traumatic Brain Injuries
Understanding Traumatic Brain Injuries: What Families Need to Know
Policy & Law
October 10, 2025
Remote Monitoring touchpoints
Remote Monitoring Touchpoints Patients Will Actually Follow
Technology
October 9, 2025
dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025

You Might also Like

eHealthGlobal HealthcareHealth ReformMedical InnovationsMobile HealthNewsTechnology

How a New Patient Experience Model Will Drive the Future of Connected Healthcare?

July 10, 2018
generic pharmaceuticals
Medical EthicsPolicy & LawPublic Health

Are Biosimilars Ethical?

May 16, 2013
eHealthPublic Health

How Much Does It Cost To Be Gluten Free? Here’s What To Know

June 5, 2019
eHealthHealth carePublic Health

3 Key Benefits of Personalizing Patient Price Transparency

September 18, 2018
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?